Top

Published in:

01-11-2012 | Original Article

Depression, fatigue, and health-related quality of life in head and neck cancer patients: a prospective pilot study

Authors: Namie Okino Sawada, Juliana Maria de Paula, Helena Megumi Sonobe, Marcia Maria Fontão Zago, Giselle Patricia Guerrero, Adriana Cristina Nicolussi

Published in: Supportive Care in Cancer | Issue 11/2012

Abstract

Purpose

To assess the prevalence of depression and fatigue symptoms in head and neck cancer patients during radiotherapy treatment and relate them symptoms with these patients’ quality of life.

Method

This is a prospective study. The Beck Depression Inventory (BDI), Piper Fatigue Scale-revised and Functional Assessment Cancer Therapy Head and Neck (FACT-H&N) were applied to 41 head and neck cancer patients at three times: at the start of treatment (T1), approximately 15 days after the start of treatment (T2) and at the end of treatment (T3), approximately 30 days after the start of the radiotherapy.

Results

The mean BDI and PIPER increased during the radiotherapy treatment. BDI scores did not demonstrate the presence of depression, although the number of symptoms increased, and the presence of fatigue rose as treatment advanced. The mean FACT H&N decreased in the middle and at the end of treatment, indicating worsening in these patients’ Quality of Life.

Conclusions

Depression and fatigue symptoms increased during radiotherapy treatment, while QoL levels decreased. This demonstrates that these symptoms are strongly correlated and that their presence negatively influenced QoL. At the start of treatment, nurses need to advise patients and plan care, offering interventions to decrease these symptoms and improve QoL.

Alvarenga LM, Ruiz MT, Pavarino-Bertelli EC, Ruback MJC, Maniglia JV, Goloni-Bertollo EM (2008) Avaliação epidemiológica de pacientes com câncer de cabeça e pescoço em um hospital universitário do noroeste do estado de São Paulo. Rev Bras Otorrinolaringol 74:68–73. doi:10.1590/S0034-72992008000100011 CrossRef

Andreoni GI, Veneziano DB, Gianotti Filho O, Marigo C, Mirra AP, Fonseca LAM (2001) Cancer incidence in eigtheen cities of the State of São Paulo, Brasil. Revista de Saúde Pública 35:362–367. doi:10.1590/S0034-89102001000400005 PubMedCrossRef

Antunes AP (2001) Princípios do planejamento terapêutico e avaliação geral do paciente oncológico. In: Carvalho MB (ed) Tratado de cirurgia de cabeça e pescoço e otorrinolaringologia. Atheneu, São Paulo, pp 21–29

Barros APB, Angelis EC, Cruz-Lourenço MT, Rigon ARS, Nishimoto IN, Kowalski LP (2006) Qualidade de vida, depressão e hipotireoidismo após laringectomia total. Rev Bras Cir Cabeça Pescoço 35(1):26–31

Bottino SMB, Fráguas R, Gattaz WF (2009) Depressão e câncer. Rev Psiq Clín 36(3):109–115. doi:10.1590/S0101-60832009000900007

Brasil. Ministério da Saúde. Conselho Nacional de Saúde. Resolução CNS 196/96. Diretrizes e normas regulamentadoras de Pesquisas envolvendo seres humanos. Brasília: Ministério da Saúde; 1996

Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2009

Bromheim H, Strain JJ, Biller HF (1999) Psychiatric aspects of head and neck surgery. Part I: new surgical thechniques and psychiatric consequences. Gen Hosp Psychiatric 13:165–176CrossRef

Brown DJF, McMillan DC, Milroy R (2005) The correlation between fatigue, psysical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103(2):377–382. doi:10.1002/cncr.20777 PubMedCrossRef

10.

Colombo J, Rahal P (2009) Alterações genéticas em câncer de cabeça e pescoço. Revista Brasileira de Cancerologia 55(2):165–174

11.

Cruciani RA (2006) Understanding and treating cancer-related fatigue. J Support Oncol 4(2):72

12.

Curran D, Giralt J, Harari PM et al (2007) Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25(16):2191–2197. doi:10.1200/JCO.2006.08.8005 PubMedCrossRef

13.

Dancey C, Reidy J (2006) Estatística Sem Matemática para Psicologia: Usando SPSS para Windows. Artmed, Porto Alegre

14.

Eakin R (2001) Câncer de cabeça e pescoço. In: Spence RAJ, Jonhston PG (eds) Oncologia. Guanabara Koogan, Rio de Janeiro, pp 139–150

15.

De Graeff A, de Leeuw JR, Hordjk GJ, Bljham GH, Winnubst JA (2000) Pretreatment factors predicting quality of life after treatment for head and neck câncer. Head Neck 22:398–407PubMedCrossRef

16.

de Leeuw JR, de Graeff A, Hordjk GJ, Bljham GH, Winnubst JÁ (2001) Prection of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck 23:892–898PubMedCrossRef

17.

Devendra AC, Chaukar MS, Rohan RW et al (2009) Quality of life in head and neck cancer survivors: a cross-sectional survey. Am J Otlaryngol 30:176–180CrossRef

18.

Geinitz H, Zimmermann FB, Stoll P et al (2001) Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 51(3):691–698. doi:10.1016/S0360-3016(01)01657-1 PubMedCrossRef

19.

Goreinstein C, Andrade L (1996) Validation of Portuguese version of Beck depression inventory and state-trait anxiety inventory in Brazilian subjects. Braz J Med Biol Res 29:453–457

20.

Gotay CC, Moore TD (1992) Assessing quality of life in head and neck cancer. Qual life Res 1:5–17PubMedCrossRef

21.

Howren MB, Christensen AJ, Karnell LH, Kunk GF (2010) Health-related quality of life in head and neck cancer survivors: impact OF PRETREATMENT DEPRESSIVE SYMPTOMS. Health Psychol 29:65–71PubMedCrossRef

22.

Infante-Cossio P, Torres-Carranza E, Cayuela A, Hens-Aumente E, Pastor-Gaitan P, Gutierrez-Perez JL (2009) Impact of treatment on quality of life for oral and oropharyngeal carcinoma. Int J Oral Maxillofac Surg 38(10):1052–1058. doi:10.1016/j.ijom.2009.06.008 PubMedCrossRef

23.

Instituto Nacional de Câncer (2008) Cancer Statistics in Brasil 2008. Available from: http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/boca/definicao. Acessed 19 november 2010

24.

Jason YK, Chan MBBS, Lannah LL, Heather HS et al (2011) The relationship between Depressive Symptoms and initial quality of life and function in head and neck cancer. Laryngoscope 121:1212–1218CrossRef

25.

Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, Kowalczyk A, Canino P, Ansarin M, Orecchia R (2007) Fatigue during head and neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys 68(2):403–415PubMedCrossRef

26.

Katz MR, Kopek N, Devins GM, Tomlinson G (2004) Screening for depression in head and neck cancer. Psycho Oncol 13:269–280CrossRef

27.

Kugaya A, Akechi T, Okuyama T et al (2000) Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 88:2817–2823PubMedCrossRef

28.

Langendijk JA, Doornaert P, de Leeuw MV et al (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26(22):3770–3777PubMedCrossRef

29.

Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst 32:57–71

30.

Melo LC, Silva MC, Bernardo JMP, Marques EB, Leite ICG (2010) Perfil epidemiológico de casos incidentes de câncer de boca e faringe. Rev Gaúcha Odontol 58(3):351–355

31.

Mota DDACF (2008) Fadiga em doentes com câncer colo-retal: fatores de risco e preditivos. University of São Paulo, Ribeirão Preto, Academic These

32.

Mota DDCF, Cruz DALM, Pimenta CAM (2005) Fadiga: uma análise do conceito. Acta paul enferm 18(3):285–293. doi:10.1590/S0103-21002005000300009 CrossRef

33.

Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoermann L, Groenvold M (2006) Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the multidimensional fatigue inventory. J Pain Symptom Manag 31(6):533–541. doi:10.1016/j.jpainsymman.2005.11.012 CrossRef

34.

Ostus AA, Aarstad AKH, Olofsson J, Aarstad HJ (2011) Health-related quality of life in long-term head and neck câncer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 36:361–368CrossRef

35.

Pasquali L (1997) Psicometria: teoria e aplicações. Editora Universidade de Brasília, Brasília

36.

Sawada NO (2002) Qualidade de vida dos pacientes com câncer de cabeça e pescoço. Academic Dissertation, University of São Paulo, Ribeirão Preto

37.

Sobrinho JA (2001) Princípios da cirurgia oncológica e ressecções clássicas em cabeça e pescoço. In: Carvalho MB (ed) Tratado de cirurgia de cabeça e pescoço e otorrinolaringologia. Atheneu, São Paulo, pp 31–37

38.

Visser MRM, Smets EMA (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Canc 6(2):101–108. doi:10.1007/s005200050142 CrossRef

39.

Wan Leugh S, Lee T, Chien C, Tsai W, Fang F (2011) Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ C30 and QLQ-H&N 35 questionnaires. BMC Cancer 11:128CrossRef

40.

Wratten CK, Kilmurray J, Nash S, Seldon M, Hamilton CS, O’Brien PC, Denham JW (2004) Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys 59(1):160–167. doi:10.1016/j.ijrobp.2003.10.008 PubMedCrossRef

41.

Young KE, White CA (2006) The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res 60(1):29–38. doi:10.1016/j.jpsychores.2005.03.011 PubMedCrossRef

Title: Depression, fatigue, and health-related quality of life in head and neck cancer patients: a prospective pilot study
Authors: Namie Okino Sawada
Juliana Maria de Paula
Helena Megumi Sonobe
Marcia Maria Fontão Zago
Giselle Patricia Guerrero
Adriana Cristina Nicolussi
Publication date: 01-11-2012
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 11/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-012-1390-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2012

Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?

A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema

Participation in cancer rehabilitation and unmet needs: a population-based cohort study

Physicians’ self-assessment of cancer pain treatment skills—more training required

Hepatitis B virus management to prevent reactivation after chemotherapy: a review

Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer